NovoCure Ltd — Director's Dealing 2018

Aug 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-08-24

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-24	Ordinary Shares	S	12216	$40.0004	Disposed	1058838	Indirect
2018-08-27	Ordinary Shares	S	13450	$40.0493	Disposed	1045388	Indirect

Footnotes

F1: On August 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 12,216 shares in multiple trades at prices ranging from $40.00 to $40.05. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

F3: On August 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,450 shares in multiple trades at prices ranging from $40.00 to $40.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.